SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77763.91
261.79 (0.34%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
91	Indraprastha Medical Corporation Ltd.	Q V+ PT	3,559 Small Cap	388.20 (-0.35%)	19.38	4.81	10.30	29.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Gujarat Themis Biosyn Ltd.	Q V+ PT	4,209 Small Cap	386.30 (-2.40%)	90.17	14.63	12.12	15.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Aarti Drugs Ltd.	Q V+ PT	3,522 Small Cap	385.85 (0.55%)	18.07	2.27	5.74	4.42	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	Fermenta Biotech Ltd.	Q V PT	1,018 Small Cap	345.85 (-1.45%)	15.83	2.41	7.46	0.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	Bajaj Healthcare Ltd.	Q V PT	1,161 Small Cap	344.75 (0.75%)	54.46	2.18	5.76	2.91	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Suven Life Sciences Ltd.	Q V+ PT	8,647 Small Cap	327.55 (9.68%)	N/A	5.75	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Advanced Enzyme Technologies Ltd.	Q V PT	3,564 Small Cap	318.25 (1.48%)	27.04	5.02	7.28	11.87	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	Health X Platform Ltd.	Q V PT	993 Small Cap	311 (0.00%)	N/A	3.67	109.54	-201.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	Park Medi World Ltd.	Q V+ PT	12,712 Small Cap	294.30 (2.17%)	347.16	14.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	Viyash Scientific Ltd.	Q V PT	12,853 Small Cap	294.20 (0.63%)	72.5	4.42	5.64	-18.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	Wanbury Ltd.	Q V+ PT	1,003 Small Cap	287.20 (0.12%)	15.17	6.95	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	Suraksha Diagnostic Ltd.	Q V PT	1,425 Small Cap	273.60 (0.85%)	44.27	5.82	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	Tarsons Products Ltd.	Q V+ PT	1,412 Small Cap	265.45 (-0.23%)	62.33	2.09	12.30	-1.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	Marksans Pharma Ltd.	Q V+ PT	11,964 Small Cap	264 (-1.14%)	39.79	7.24	22.06	32.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Artemis Medicare Services Ltd.	Q V PT	4,122 Small Cap	260.40 (0.48%)	39.85	4.74	10.15	32.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Indoco Remedies Ltd.	Q V+ PT	2,257 Small Cap	244.55 (0.49%)	N/A	2.05	6.54	-182.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	7,761 Small Cap	239.15 (0.02%)	5	5.82	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,554 Small Cap	236.05 (0.36%)	36.07	6.54	11.13	39.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Laxmi Dental Ltd.	Q V PT	1,254 Small Cap	228.10 (1.45%)	76.32	5.07	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Hikal Ltd.	Q V+ PT	2,740 Small Cap	222.20 (-0.43%)	N/A	2.29	4.29	-1.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Dishman Carbogen Amcis Ltd.	Q V+ PT	3,082 Small Cap	196.60 (4.57%)	31.63	0.46	5.82	-33.01	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Kopran Ltd.	Q V PT	939 Small Cap	194.55 (4.07%)	30.9	2.1	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	Piramal Pharma Ltd.	Q V PT	23,418 Small Cap	175.90 (4.58%)	33.45	2.9	10.23	-6.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	Shalby Ltd.	Q V PT	1,862 Small Cap	172.35 (-0.63%)	16.49	1.49	12.52	25.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Fabtech Technologies Ltd.	Q V PT	738 Small Cap	166.10 (2.69%)	30.44	1.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	GPT Healthcare Ltd.	Q V PT	1,301 Small Cap	158.55 (1.34%)	30.81	4.83	13.96	24.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	4,199 Small Cap	143.05 (-4.76%)	30.51	2.33	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,180 Small Cap	133.65 (0.04%)	N/A	N/A	19.21	12.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	Gujarat Kidney And Super Speciality Ltd.	Q V+ PT	1,024 Small Cap	129.90 (-0.84%)	103.44	4.16	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	Themis Medicare Ltd.	Q V PT	1,091 Small Cap	118.45 (-0.59%)	N/A	4.06	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	327.55	9.68%
Shree Ganesh Remed.	673.90	4.90%
Piramal Pharma	175.90	4.58%
Dishman Carbogen Amc	196.60	4.57%
Kopran	194.55	4.07%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Rubicon Research	1,302.75	-5.22%
IOL Chem & Pharma	143.05	-4.76%
Bliss GVS Pharma	506.15	-3.87%
Poly Medicure	1,680.05	-3.32%
3B Blackbio Dx	1,172.50	-2.92%

News about Top Pharma Companies in India

Jul, 2026

Piramal Pharma informs about newspaper advertisement

Pursuant to Regulation 30 of the SEBI Listing Regulations, Piramal Pharma has informed that it enclosed copies of newspaper advertisement published in Business Standard (English) and Mumbai Lakshadweep (Marathi), in respect of dispatch of Notice of the 6th Annual General Meeting of the Company scheduled to be held on Thursday, July 30, 2026 at 3:00 pm (IST) through Video Conference/ Other Audio Visual Means and information relating to e-voting facility.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn has informed that the Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business Group (India).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Themis Medicare informs about disclosures

Themis Medicare has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Vividhmargi Trust.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business Group (India).

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Fabtech Technologies informs about outcome of postal ballot

Fabtech Technologies has informed that the Company had sought consent from members of the Company on the following resolutions through Postal Ballot notice dated May 25, 2026: Appointment of Rupal Dhiren Haria (DIN: 10624643) as a Non-Executive Independent Director of the Company; and Appointment of Bharti Khanna (DIN: 05147844) as a Non-Executive Independent Director of the Company. Based on the report issued by our Scrutinizer, CS Rachana Shanbhag, Partner of DA Kamat & Co., Company Secretaries, (FCS: 8227/ CP: 9297), the above resolutions have been passed and the same are deemed to have been approved on the last date of e-voting period i.e., Tuesday, June 30, 2026. The voting results in the format prescribed under Regulation 44(3) of SEBI. Listing. Regulations, along with the Scrutinizer's Report on remote e-voting, in respect of above resolutions are attached. The Voting Results along with the Scrutinizer's Report are available on the Company's website www.fabtechnologies.com and also on the website of NSDL at https://www.evoting.nsdl.com/.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Gujarat Themis Biosyn informs about disclosures

Gujarat Themis Biosyn has informed that the Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Abbott India Ltd.	54,930 Crore
2	Neuland Laboratories Ltd.	24,270 Crore
3	Apollo Hospitals Enterprise Ltd.	1,27,930 Crore
4	Astrazeneca Pharma India Ltd.	20,745 Crore
5	Divis Laboratories Ltd.	1,79,471 Crore
6	Procter & Gamble Health Ltd.	10,560 Crore
7	Kovai Medical Center & Hospital Ltd.	6,611 Crore
8	Alkem Laboratories Ltd.	66,606 Crore
9	Dr Agarwals Eye Hospital Ltd.	2,432 Crore
10	Torrent Pharmaceuticals Ltd.	1,61,290 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,850	54,930	35.39	11.51	24.16	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	74.55	19.23	39.18	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,326	41,550	39.35	9.18	26.59	25.35
Lupin Ltd. (M)	Somewhat Good	2,476	1,13,215	21.23	5.04	12.28	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,141	1,13,815	22.58	4.38	13.82	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,542	83,293	103
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,363	37,944	44.17
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	42.84
Aurobindo Pharma Ltd. (M)	Very Good	1,620	93,217	40.20
Gland Pharma Ltd. (S)	Very Good	2,461	40,588	31.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,363	37,944	56.29	9.40	34.09	15.51
Mankind Pharma Ltd. (M)	Very Good	2,531	1,04,535	51.30	6.38	32.20	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,326	41,550	39.35	9.18	26.59	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,375	1,14,730	27.34	3.04	15.25	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	74.55	19.23	39.18	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,141	1,13,815	22.58	4.38	13.82	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,905	4,56,989	39.81	5.47	22.81	23.50
Abbott India Ltd. (M)	Very Good	25,850	54,930	35.39	11.51	24.16	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,375	1,14,730	27.34	3.04	15.25	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,210	62,362	45.79	5.93	12.16	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Piramal Pharma informs about newspaper advertisement

Gujarat Themis Biosyn informs about disclosures

Themis Medicare informs about disclosures

Gujarat Themis Biosyn informs about disclosures

Fabtech Technologies informs about outcome of postal ballot

Gujarat Themis Biosyn informs about disclosures

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.